Jul. 8 at 7:59 PM
$BKYI $BKYI – BIO-key International – RELISTED TO NASDAQ TODAY
BIO-key (Identity & Access Management / biometric authentication) resumed trading on Nasdaq this morning, July 8, after being suspended to OTC back in May for non-compliance (late 10-K/10-Q filings + bid price rule). Nasdaq's Hearings Panel restored the listing on June 16 after the company caught up on filings and met the minimum bid price requirement.
Setup:
Float: ~1.07M
Sector: Cybersecurity / biometric IAM
Catalyst: Fresh Nasdaq relist after OTC suspension: classic low-float "back on the big board" play
Fundamentals : Q1 revenue
$2.15M (+34% YoY), narrowing losses, guiding ~
$2.8M Q2 and ~
$5M 1H26 revenue with expected 1H profitability
Comparison: Last relist I traded was
$CODX which gave a boombastic move. Similar mechanics here: tiny float, OTC-to-Nasdaq relist headline, renewed institutional eligibility. Worth watching if it gets the same kind of attention.
Do your own dd and charting fam.